DNLI logo

Denali Therapeutics (DNLI) Short term debt

Annual short term debt:

$12.03M+$4.77M(+65.76%)
December 31, 2024

Summary

  • As of today (June 17, 2025), DNLI annual short term debt is $12.03 million, with the most recent change of +$4.77 million (+65.76%) on December 31, 2024.
  • During the last 3 years, DNLI annual short term debt has risen by +$6.58 million (+120.69%).
  • DNLI annual short term debt is now at all-time high.

Performance

DNLI Short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIbalance sheet metrics

quarterly short term debt:

$8.59M-$3.45M(-28.66%)
March 31, 2025

Summary

  • As of today (June 17, 2025), DNLI quarterly short term debt is $8.59 million, with the most recent change of -$3.45 million (-28.66%) on March 31, 2025.
  • Over the past year, DNLI quarterly short term debt has increased by +$1.07 million (+14.28%).
  • DNLI quarterly short term debt is now -28.66% below its all-time high of $12.03 million, reached on December 31, 2024.

Performance

DNLI quarterly short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIbalance sheet metrics

Short term debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

DNLI Short term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+65.8%+14.3%
3 y3 years+120.7%+51.7%
5 y5 years+228.3%+108.3%

DNLI Short term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+120.7%-28.7%+51.7%
5 y5-yearat high+228.3%-28.7%+108.3%
alltimeall timeat high>+9999.0%-28.7%>+9999.0%

DNLI Short term debt History

DateAnnualQuarterly
Mar 2025
-
$8.59M(-28.7%)
Dec 2024
$12.03M(+65.8%)
$12.03M(+49.8%)
Sep 2024
-
$8.04M(+3.4%)
Jun 2024
-
$7.77M(+3.4%)
Mar 2024
-
$7.51M(+3.5%)
Dec 2023
$7.26M(-0.8%)
$7.26M(+3.5%)
Sep 2023
-
$7.01M(+3.5%)
Jun 2023
-
$6.77M(+3.6%)
Mar 2023
-
$6.54M(-10.6%)
Dec 2022
$7.32M
$7.32M(+3.5%)
Sep 2022
-
$7.07M(+20.4%)
DateAnnualQuarterly
Jun 2022
-
$5.87M(+3.7%)
Mar 2022
-
$5.66M(+3.8%)
Dec 2021
$5.45M(+16.3%)
$5.45M(+3.8%)
Sep 2021
-
$5.25M(+3.9%)
Jun 2021
-
$5.05M(+3.7%)
Mar 2021
-
$4.88M(+4.0%)
Dec 2020
$4.69M(+28.0%)
$4.69M(+4.0%)
Sep 2020
-
$4.51M(+4.1%)
Jun 2020
-
$4.33M(+5.1%)
Mar 2020
-
$4.12M(+12.4%)
Dec 2019
$3.67M(>+9900.0%)
$3.67M(>+9900.0%)
Dec 2018
$0.00
$0.00

FAQ

  • What is Denali Therapeutics annual short term debt?
  • What is the all time high annual short term debt for Denali Therapeutics?
  • What is Denali Therapeutics annual short term debt year-on-year change?
  • What is Denali Therapeutics quarterly short term debt?
  • What is the all time high quarterly short term debt for Denali Therapeutics?
  • What is Denali Therapeutics quarterly short term debt year-on-year change?

What is Denali Therapeutics annual short term debt?

The current annual short term debt of DNLI is $12.03M

What is the all time high annual short term debt for Denali Therapeutics?

Denali Therapeutics all-time high annual short term debt is $12.03M

What is Denali Therapeutics annual short term debt year-on-year change?

Over the past year, DNLI annual short term debt has changed by +$4.77M (+65.76%)

What is Denali Therapeutics quarterly short term debt?

The current quarterly short term debt of DNLI is $8.59M

What is the all time high quarterly short term debt for Denali Therapeutics?

Denali Therapeutics all-time high quarterly short term debt is $12.03M

What is Denali Therapeutics quarterly short term debt year-on-year change?

Over the past year, DNLI quarterly short term debt has changed by +$1.07M (+14.28%)
On this page